Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
+$128M |
| 2 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$32.6M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$28.6M |
| 4 |
Tyler Technologies
TYL
|
+$26.9M |
| 5 |
Brown & Brown
BRO
|
+$19.5M |
Top Sells
| 1 |
Apple
AAPL
|
+$284M |
| 2 |
CELG
Celgene Corp
CELG
|
+$231M |
| 3 |
Microsoft
MSFT
|
+$184M |
| 4 |
Alibaba
BABA
|
+$158M |
| 5 |
Amazon
AMZN
|
+$104M |
Sector Composition
| 1 | Technology | 21.52% |
| 2 | Healthcare | 14.66% |
| 3 | Consumer Discretionary | 11.66% |
| 4 | Communication Services | 10.17% |
| 5 | Industrials | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Arrow Financial
AROW
$478M
| $975K | ﹤0.01% |
29,025
+901
| +3% | +$30.3K |
|
|
BDSI
2152
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $975K | ﹤0.01% |
+154,300
| New | +$975K |
|
2153
Johnson Outdoors
JOUT
$422M
| $974K | ﹤0.01% |
12,700
+400
| +3% | +$30.7K |
|
2154
Smith & Wesson
SWBI
$415M
| $973K | ﹤0.01% |
136,410
+4,424
| +3% | +$31.6K |
|
|
AXDX
2155
DELISTED
Accelerate Diagnostics
AXDX
| $970K | ﹤0.01% |
5,740
+190
| +3% | +$32.1K |
|
2156
MacroGenics
MGNX
$100M
| $967K | ﹤0.01% |
88,900
+2,700
| +3% | +$29.4K |
|
2157
Phibro Animal Health
PAHC
$1.61B
| $966K | ﹤0.01% |
38,900
+1,100
| +3% | +$27.3K |
|
|
MITT
2158
AG Mortgage Investment Trust
MITT
$244M
| $965K | ﹤0.01% |
20,867
+434
| +2% | +$20.1K |
|
2159
Kenon Holdings
KEN
$2.43B
| $964K | ﹤0.01% |
45,182
+5,121
| +13% | +$109K |
|
2160
OrthoPediatrics
KIDS
$493M
| $963K | ﹤0.01% |
20,500
+4,100
| +25% | +$193K |
|
|
GOGL
2161
DELISTED
Golden Ocean Group
GOGL
| $962K | ﹤0.01% |
165,705
+4,637
| +3% | +$26.9K |
|
|
HIBB
2162
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $962K | ﹤0.01% |
34,300
+800
| +2% | +$22.4K |
|
2163
Intellia Therapeutics
NTLA
$1.23B
| $961K | ﹤0.01% |
65,500
+5,500
| +9% | +$80.7K |
|
2164
First Financial Corporation Common Stock
THFF
$691M
| $961K | ﹤0.01% |
21,026
+500
| +2% | +$22.9K |
|
2165
Opko Health
OPK
$1.11B
| $953K | ﹤0.01% |
648,100
+12,900
| +2% | +$19K |
|
2166
Camping World
CWH
$1.04B
| $949K | ﹤0.01% |
64,400
+1,700
| +3% | +$25.1K |
|
2167
OraSure Technologies
OSUR
$242M
| $949K | ﹤0.01% |
118,200
+1,900
| +2% | +$15.3K |
|
2168
Ituran Location and Control
ITRN
$696M
| $948K | ﹤0.01% |
37,725
| – | – |
|
|
DO
2169
DELISTED
Diamond Offshore Drilling
DO
| $948K | ﹤0.01% |
131,853
+3,900
| +3% | +$28K |
|
2170
Amneal Pharmaceuticals
AMRX
$3.14B
| $946K | ﹤0.01% |
196,300
+25,100
| +15% | +$121K |
|
|
WSR
2171
Whitestone REIT
WSR
$664M
| $944K | ﹤0.01% |
69,300
+2,700
| +4% | +$36.8K |
|
|
PLYA
2172
DELISTED
Playa Hotels & Resorts
PLYA
| $940K | ﹤0.01% |
111,900
+2,600
| +2% | +$21.8K |
|
|
PETQ
2173
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $937K | ﹤0.01% |
37,400
+1,700
| +5% | +$42.6K |
|
2174
Akebia Therapeutics
AKBA
$782M
| $935K | ﹤0.01% |
147,885
+4,100
| +3% | +$25.9K |
|
2175
Resources Connection
RGP
$172M
| $932K | ﹤0.01% |
57,100
| – | – |
|